Learn about adrenal mass, also known as adrenal tumor or adrenal lesion, diagnosis. This resource provides information on healthcare best practices for clinical documentation and medical coding of adrenal masses, adrenal tumors, and adrenal lesions. Find guidance on appropriate ICD-10 and SNOMED CT codes for accurate reporting and billing related to adrenal mass diagnosis. Improve your medical documentation and coding accuracy with this comprehensive guide for adrenal lesions, tumors, and masses.
Abnormal growth in the adrenal gland, can be benign or cancerous.
Often asymptomatic. May cause high blood pressure, abdominal pain, or hormonal imbalances.
Detected incidentally on imaging or during investigation for hormonal issues. Requires specialist evaluation.
Complete code families applicable to D49.7
| Description | When to use |
|---|---|
| Abnormal growth in adrenal gland. | Use for any undefined adrenal growth found on imaging. |
| Benign adrenal tumor. | Use when imaging or biopsy confirms benign adrenal adenoma. Consider specific subtypes. |
| Hormone-secreting adrenal tumor. | Use when the adrenal mass is causing excess hormone production. Specify hormone. |
Missing laterality (right, left, bilateral) for adrenal mass impacts accurate coding and reimbursement.
Unclear documentation of benign vs. malignant nature affects code selection and potential treatment.
If incidentally found, proper coding as incidentaloma vs. primary diagnosis requires specific documentation.
Confirm adrenal mass location with imaging report (ICD-10 D35.0)
Evaluate size and characteristics for malignancy risk (SNOMED CT 307936000)
Review hormonal function tests (cortisol, aldosterone) for hyperfunction
Document incidentaloma status if found incidentally (patient safety)
Patient presents with concerns regarding a potential adrenal mass, also known as an adrenal tumor or adrenal lesion. Presenting symptoms include (list specific symptoms e.g., abdominal pain, flank pain, hypertension, fatigue, weight changes, etc.). Physical examination findings include (document relevant findings e.g., palpable mass, abdominal tenderness, etc.). Differential diagnosis includes adrenal adenoma, adrenal carcinoma, pheochromocytoma, adrenal cyst, and myelolipoma. Imaging studies, including abdominal CT scan with contrast, adrenal protocol CT, and MRI abdomen, have been ordered to characterize the lesion and evaluate for size, location, and characteristics suggestive of malignancy. Laboratory tests, including serum cortisol, aldosterone, renin, and urinary metanephrines, are being conducted to assess adrenal function and screen for hormonal hypersecretion. The patient's medical history includes (list relevant medical history e.g., hypertension, diabetes, family history of endocrine disorders, etc.). The patient's surgical history includes (list relevant surgical history). Current medications include (list current medications). The patient has been informed about the potential need for adrenalectomy, either laparoscopic adrenalectomy or open adrenalectomy, depending on the final diagnosis and size of the mass. Further management will be determined based on imaging and laboratory results. Patient education provided on adrenal mass symptoms, adrenal cancer risk factors, adrenal incidentaloma management, and the importance of follow-up care. The patient will be scheduled for a follow-up appointment to discuss results and treatment options. ICD-10 codes (list relevant ICD-10 codes e.g., D35.0, D35.1, etc.) are being considered.
While non-contrast CT is often the initial imaging modality for adrenal incidentalomas, differentiating benign from malignant adrenal masses requires further characterization. Contrast-enhanced CT with washout calculations can offer valuable information, though it's not always definitive. MRI can be helpful, particularly in characterizing lipid-rich adenomas. Chemical shift MRI can be especially useful for this purpose. Ultimately, the decision for further imaging or biopsy should be guided by factors like size, patient characteristics, and imaging features concerning for malignancy. Explore how S10.AI can enhance the interpretation of adrenal mass imaging and facilitate clinical decision-making.
Current guidelines, including those from the American College of Radiology and the Endocrine Society, generally recommend hormonal evaluation (including assessment of aldosterone, cortisol, and metanephrines) for incidental adrenal masses, even in the absence of overt symptoms. For masses < 4cm with benign imaging features and no biochemical evidence of hormone hypersecretion, repeat imaging in 6-12 months is often recommended to ensure stability. However, in a hypertensive patient, careful assessment for primary aldosteronism is particularly important, as aldosterone-producing adenomas can contribute to hypertension. Consider implementing a standardized adrenal mass evaluation protocol within your practice to ensure consistent and evidence-based management. Learn more about how S10.AI can assist in developing customized diagnostic pathways for adrenal incidentalomas.
Adrenalectomy is typically indicated for adrenal masses demonstrating concerning features for malignancy, such as size > 4cm, rapid growth, irregular borders, or evidence of local invasion. Functional adrenal tumors causing clinically significant hormone excess also often warrant surgical resection. The decision between laparoscopic and open adrenalectomy depends on several factors, including tumor size, suspected malignancy, surgeon experience, and patient comorbidities. Laparoscopic adrenalectomy is generally preferred for smaller, benign tumors, offering advantages like reduced postoperative pain and faster recovery. Open adrenalectomy may be necessary for larger tumors or those with suspected malignant involvement. Explore S10.AI's resources on the latest surgical techniques for adrenalectomy and how AI can assist in preoperative planning.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.